Showing 1,581 - 1,600 results of 2,530 for search '"vaccines"', query time: 0.05s Refine Results
  1. 1581

    Advancements in Liposomal Nanomedicines: Innovative Formulations, Therapeutic Applications, and Future Directions in Precision Medicine by Izadiyan Z, Misran M, Kalantari K, Webster TJ, Kia P, Basrowi NA, Rasouli E, Shameli K

    Published 2025-01-01
    “…The recent COVID-19 pandemic has accelerated research in liposomal-based vaccines and antiviral therapies, underscoring the need for improved delivery mechanisms to overcome challenges like rapid clearance and organ toxicity. …”
    Get full text
    Article
  2. 1582

    Evaluation of In-House ELISA for Antirabies Antibodies Detection in Domestic Canine by Yul Fitria, Niko Febrianto, Rahmi E. Putri, Ibenu Rahmadani, Didik T. Subekti

    Published 2023-01-01
    “…Postvaccination monitoring should be carried out to evaluate the success of vaccination by measuring antibody titers in serum of vaccinated dogs. …”
    Get full text
    Article
  3. 1583

    Developing a taxonomy to describe offspring outcomes in studies involving pregnant mammals' exposure to non-tobacco nicotine: A systematic scoping review. by Lucy Phillips, Ross Thomson, Tom Coleman-Haynes, Sue Cooper, Felix Naughton, Lisa Mcdaid, Joanne Emery, Tim Coleman

    Published 2023-01-01
    “…We excluded studies that investigated exposure to only smoking, e-cigarettes, nicotine vaccines, or studies with no 'nicotine only' group. …”
    Get full text
    Article
  4. 1584

    Testing and identification of bovine viral diarrhea virus isolates recovered in Russia between 2019 and 2022 by R. I. Bubyakin, S. V. Kononova, I. N. Shumilova, O. P. Byadovskaya, A. O. Krotova, A. V. Kononov

    Published 2023-12-01
    “…Studying the agents of bovine viral diarrhea (BVD) is an important task given the high probability of new isolate introduction into the Russian Federation, as well as the need to take into account the genotype and subgenotype of the virus circulating in a herd when developing vaccines and diagnostic kits for the infection. During the work performed, 6 BVD virus isolates were recovered and identified. …”
    Get full text
    Article
  5. 1585

    Therapeutic development to accelerate malaria control through intentional intervention layering by Lydia Braunack-Mayer, Narimane Nekkab, Josephine Malinga, Sherrie L. Kelly, Evelyn Ansah, Joerg J. Moehrle, Melissa A. Penny

    Published 2025-01-01
    “…Abstract The clinical development of novel vaccines, injectable therapeutics, and oral chemoprevention drugs has the potential to deliver significant advancements in the prevention of Plasmodium falciparum malaria. …”
    Get full text
    Article
  6. 1586

    Influenza D virus in cattle (review) by S. V. Koteneva, A. G. Glotov, T. I. Glotova, A. V. Nefedchenko

    Published 2024-03-01
    “…There are currently no vaccines or specific treatment for influenza D virus. …”
    Get full text
    Article
  7. 1587

    Inhibition of STING-mediated type I IFN signaling by African swine fever virus DP71L by Lakmal Ranathunga, Sachini Abesinghe, Ji-Won Cha, Niranjan Dodantenna, Kiramage Chathuranga, Asela Weerawardhana, D. K. Haluwana, Nuwan Gamage, Jong-Soo Lee

    Published 2025-02-01
    “…Taken together, these results highlight the important role of DP71L with respect to inhibition of interferon responses and provide guidance for a better understanding of ASFV pathogenesis and the development of live attenuated ASFV vaccines.…”
    Get full text
    Article
  8. 1588

    Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges by Man Wang, Fei Yu, Yuan Zhang

    Published 2025-01-01
    “…Multiple forms of cancer immunotherapy, including immune checkpoint inhibitors (ICIs), adoptive cell therapy and cancer vaccines, have become widely available. However, the effectiveness of these immunotherapies is not much satisfying. …”
    Get full text
    Article
  9. 1589

    Antihepatitis B Virus Activity of a Protein-Enriched Fraction from Housefly (Musca domestica) in a Stable HBV-Producing Cell Line by Xuemei Lu, Xiaobao Jin, Jie Wang, Fujiang Chu, Jiayong Zhu

    Published 2014-01-01
    “…Hepatitis B virus (HBV) infection remains a major public health problem. Although several vaccines and therapeutic strategies are currently being implemented to combat HBV virus, effective antiviral therapy against HBV infection has not been fully developed. …”
    Get full text
    Article
  10. 1590

    Relationship between RSV-hospitalized children and meteorological factors: a time series analysis from 2017 to 2023 by Shuying Wang, Yifan Wang, Yingxue Zou, Cheng-liang Yin

    Published 2025-02-01
    “…Furthermore, continued research into vaccines and therapeutic drugs remains indispensable for augmenting public health outcomes.…”
    Get full text
    Article
  11. 1591

    Replication-transcription complex of coronaviruses: functions of individual viral non-structural subunits, properties and architecture of their complexes by E. L. Mishchenko, V. A. Ivanisenko

    Published 2022-04-01
    “…Severe acute respiratory syndrome CoV (SARS-CoV), Middle East respiratory syndrome CoV (MERS-CoV), and the novel coronavirus (2019-nCoV, SARS-CoV-2) have been identif ied as causing global pandemics. Clinically tested vaccines are widely used to control rapidly spreading, acute, and often severe infections; however, effective drugs are still not available. …”
    Get full text
    Article
  12. 1592

    STUDY ON THE ESTIMATION OF SARS-CoV-2 VIRUS PATHOGENS’ TRANSMISSION PROBABILITIES FOR DIFFERENT PUBLIC BUS TRANSPORT SERVICE SCENARIOS by Rafał BURDZIK, Niko SPEYBROECK

    Published 2023-09-01
    “…The study draws on scenarios from the first and second waves of the COVID-19 pandemic in Poland, a period that was devastatingly marked by the lack of available vaccines. This study aims to add value to the scientific community by offering an estimation of the likelihood of SARS-CoV-2 transmission in public transport and a preliminary risk assessment for COVID-19 infection, considering the number of active, non-isolated COVID-19 cases in the Polish population. …”
    Get full text
    Article
  13. 1593

    Experimental Immunization Based on Plasmodium Antigens Isolated by Antibody Affinity by Ali N. Kamali, Patricia Marín-García, Isabel G. Azcárate, Antonio Puyet, Amalia Diez, José M. Bautista

    Published 2015-01-01
    “…Vaccines blocking malaria parasites in the blood-stage diminish mortality and morbidity caused by the disease. …”
    Get full text
    Article
  14. 1594

    Scoping review of the applications of peptide microarrays on the fight against human infections. by Arthur Vengesai, Maritha Kasambala, Hamlet Mutandadzi, Tariro L Mduluza-Jokonya, Takafira Mduluza, Thajasvarie Naicker

    Published 2022-01-01
    “…<h4>Conclusion</h4>The most important application of peptide microarrays was found to be B-cell epitope mapping or antibody profiling to identify diagnostic and vaccine targets. Immunosignatures identified by random peptide microarrays were found to be applied in the diagnosis of infections and interrogation of vaccine responses. …”
    Get full text
    Article
  15. 1595

    Calreticulin as an Adjuvant In Vivo to Promote Dendritic Cell Maturation and Enhance Antigen-Specific T Lymphocyte Responses against Melanoma by Zheng Gong, Ming Chen, Jie Miao, Chao-Jie Han, Qiao Zhong, Fang-Yuan Gong, Xiao-Ming Gao

    Published 2022-01-01
    “…Our results demonstrate that CRT/39-272 can be used as a potential new adjuvant for tumor vaccines, and this finding may be useful in tumor vaccine development.…”
    Get full text
    Article
  16. 1596

    Identification of CTL Epitopes on Efflux Pumps of the ATP-Binding Cassette and the Major Facilitator Superfamily of Mycobacterium tuberculosis by Yan Lin, Yu Dong, Yanfeng Gao, Ranran Shi, Yubing Li, Xiuman Zhou, Wenwen Liu, Guodong Li, Yuanming Qi, Yahong Wu

    Published 2021-01-01
    “…The epitopes identified here provide a foundation for the diagnosis and treatment of patients infected with drug resistant and the future development of a multiepitope vaccine.…”
    Get full text
    Article
  17. 1597

    Proline isomerization modulates the bacterial IsdB/hemoglobin interaction: an atomic force spectroscopy study by Francesca Pancrazi, Omar De Bei, Francesco Lavecchia di Tocco, Marialaura Marchetti, Barbara Campanini, Salvatore Cannistraro, Stefano Bettati, Anna Rita Bizzarri

    Published 2025-02-01
    “…Abstract Iron surface determinant B (IsdB), a Staphylococcus aureus (SA) surface protein involved in both heme iron acquisition from host hemoglobin (Hb) and bacterial adhesion, is a proven virulence factor that can be targeted for the design of antibacterial molecules or vaccines. Recent single-molecule experiments on IsdB interaction with cell adhesion factors revealed an increase of the complex lifetime upon applying a stronger force (catch bond); this was suggested to favor host invasion under shear stress. …”
    Get full text
    Article
  18. 1598

    Dengue severity by serotype and immune status in 19 years of pediatric clinical studies in Nicaragua. by Federico Narvaez, Carlos Montenegro, Jose G Juarez, José Victor Zambrana, Karla Gonzalez, Elsa Videa, Sonia Arguello, Fanny Barrios, Sergio Ojeda, Miguel Plazaola, Nery Sanchez, Daniel Camprubí-Ferrer, Guillermina Kuan, Gabriela Paz Bailey, Eva Harris, Angel Balmaseda

    Published 2025-01-01
    “…<h4>Conclusions</h4>These findings demonstrate differences in dengue severity by serotype and immune status and emphasize the critical need for a dengue vaccine with balanced effectiveness against all four serotypes, particularly as existing vaccines show variable efficacy by serotype and serostatus.…”
    Get full text
    Article
  19. 1599

    Sealless Production Ultracentrifuge and Its Magnetically Self-Bearing Openable Motors for Purification in Viral Nanotechnology by Emanuel J. Hubmann, Daniel Steinert, Thomas Nussbaumer, Johann W. Kolar

    Published 2025-01-01
    “…Viral nanotechnology enables new possibilities for gene therapies and vaccines. However, the manufacturing of viral vectors lacks a satisfactory production capable method for purification of full capsids. …”
    Get full text
    Article
  20. 1600

    Sunitinib Combined with Th1 Cytokines Potentiates Apoptosis in Human Breast Cancer Cells and Suppresses Tumor Growth in a Murine Model of HER-2pos Breast Cancer by Nirmala Ghimirey, Chase Steele, Brian J. Czerniecki, Gary K. Koski, Loral E. Showalter

    Published 2021-01-01
    “…To explore the possibility of combining targeted drugs with Th1-polarizing vaccines, we undertook a study to examine the impact of combining Th1 cytokines with the relatively broad-spectrum receptor tyrosine kinase antagonist, sunitinib. …”
    Get full text
    Article